Eyepoint Pharmaceuticals Inc (EYPT) valuation · rev $31.4M
Eyepoint Pharmaceuticals Inc (EYPT) rev $31.4M.
| Metric | Value |
|---|---|
| Market cap | $1.10B |
| Revenue | $31.4M |
| P/S | 35.1 |
| P/B | 4.7 |
EYPT valuation FAQ
What is EYPT's market cap?
Eyepoint Pharmaceuticals Inc (EYPT) market cap is $1.10B on the latest cached fundamentals snapshot.
What is EYPT's latest revenue?
Latest cached Eyepoint Pharmaceuticals Inc (EYPT) revenue was $31.4M. Statements: https://lician.com/financials/eypt
What is EYPT's price-to-sales ratio?
Eyepoint Pharmaceuticals Inc (EYPT) price-to-sales (P/S) is 35.1, cached market cap $1.10B divided by revenue $31.4M.
What is EYPT's price-to-book ratio?
Eyepoint Pharmaceuticals Inc (EYPT) price-to-book (P/B) is 4.7 on the latest cached fundamentals snapshot.
How many EYPT valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Eyepoint Pharmaceuticals Inc (EYPT): Market cap, Revenue, P/S, and P/B.
Where is EYPT valuation listed?
Cached valuation multiples for Eyepoint Pharmaceuticals Inc (EYPT) are listed at https://lician.com/valuation/eypt.
Not investment advice. Cached rows, not a live tape.